Opticyte
PrivateLast Round
Convertible Debt
Dec 5, 2024
Total Funding Raised
$5.7M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Opticyte is a medical device company that develops noninvasive technology for real-time monitoring of cellular oxygenation to aid in the early detection and prevention of organ failure.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Sensors
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Opticyte Comparables
Compare Opticyte with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ViOptix, Inc. | 87% | |
| Spectros Medical Devices | 87% | |
| Envello Medical | 84% |
Opticyte Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Dec 5, 2024 | ||||
| Crowdfunding | Oct 31, 2024 | ||||
| Seed | Nov 1, 2020 | ||||
| Grant | May 1, 2020 |
Opticyte Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| FBomb Angels | Convertible Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors grew 92% MoM.
- Apr 17, 2026
Monthly visitors increased 33% MoM, reaching 1.2K.
Opticyte Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Opticyte's valuation, stock price, and market status.
Is Opticyte a public or private company?
Opticyte is a private company.
What is the current stock price of Opticyte?
Opticyte is a private company with no public stock price. No recent secondary market data is available.
How much is Opticyte worth (valuation)?
Valuation information for Opticyte is not publicly available.
Can I buy Opticyte stock?
Opticyte shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Opticyte's last funding round?
Opticyte's most recent funding round was Convertible Debt on December 5, 2024.
Who are the main investors in Opticyte?
Key investors in Opticyte include NIH RADx, FBomb Angels.
Will Opticyte IPO soon?
No public IPO plans have been announced for Opticyte.
How can I track Opticyte secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Opticyte's secondary market activity and sign up for updates.